Search research articles
Contact Us
Filters
Showing results (181-190 of 225) with videos related to
Page
of 23
Sort By:
JAMA Oncology
|
May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
David A Reardon, Alba A Brandes, Antonio Omuro, et al.
Neuro-Oncology
|
February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults
Michael Weller, Emilie Le Rhun, Martin Van den Bent, et al.
Cell Reports. Medicine
|
June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma
Juanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Neuro-Oncology
|
February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal
Emilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.
Acta Neuropathologica
|
March 21, 2018
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
Marian Christoph Neidert, Daniel Johannes Kowalewski, Manuela Silginer, et al.
Neuro-Oncology
|
July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
Wolfgang Wick, Patrick Roth, Christian Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?
Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology
|
August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 5, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity
Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, et al.
Nature Reviews. Clinical Oncology
|
December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Michael Weller, Martin van den Bent, Matthias Preusser, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 225) with videos related to
Sort By:
Page
of 23
JAMA Oncology
|
May 22, 2020
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial
David A Reardon, Alba A Brandes, Antonio Omuro, et al.
Neuro-Oncology
|
February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults
Michael Weller, Emilie Le Rhun, Martin Van den Bent, et al.
Cell Reports. Medicine
|
June 18, 2025
A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma
Juanita Suzanne Lopez, Simon Haefliger, Ruth Plummer, et al.
Neuro-Oncology
|
February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal
Emilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.
Acta Neuropathologica
|
March 21, 2018
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
Marian Christoph Neidert, Daniel Johannes Kowalewski, Manuela Silginer, et al.
Neuro-Oncology
|
July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
Wolfgang Wick, Patrick Roth, Christian Hartmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?
Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology
|
August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 5, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity
Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert, et al.
Nature Reviews. Clinical Oncology
|
December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Michael Weller, Martin van den Bent, Matthias Preusser, et al.
Page
of 23